|

Non-Invasive Diagnostic Tests for MASLD in Pediatric Population

RECRUITINGN/ASponsored by Emory University
Actively Recruiting
PhaseN/A
SponsorEmory University
Started2024-01-18
Est. completion2026-01-31
Eligibility
Age2 Years – 20 Years
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT06218589

Summary

This study aims to test the utility of Velacur ultrasound as a non-invasive, rapid, point of care diagnostic tool for detecting the presence and amount of hepatic steatosis in children and adolescents aged 2 - 20 years.

Eligibility

Age: 2 Years – 20 YearsHealthy volunteers accepted
Inclusion Criteria:

* Males and females age 2-20 years with suspicion of MASLD or presenting to liver clinic for evaluation of liver disease, including possible MASLD
* For participants choosing to do MRI they have to be able to undergo MRI without sedation
* Written/verbal informed consent from parent or legal guardian
* Written/verbal informed assent from the child when indicated by age

Exclusion Criteria:

* Ascites
* Pregnancy
* Failure to give consent or assent
* Have an implanted electronic device such as pacemaker, neurostimulator, or cochlear implant

Conditions3

Liver DiseaseMetabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver Disease NAFLD

Locations2 sites

Children's Healthcare of Atlanta (CHOA)
Atlanta, Georgia, 30322
Emory Children's Center
Atlanta, Georgia, 30322

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.